GFS vs TSEM

GFS presents a dichotomy between strong operational execution and poor deterministic valuation. While the Piotroski F-Score of 4/9 indicates stable financial health and the balance sheet is exceptionally clean (Debt/Equity 0.14), the stock trades at a significant premium to its Graham Number ($27.97) and Intrinsic Value ($11.34). Consistent earnings beats and positive EPS growth are offset by stagnant 0% revenue growth and bearish insider sentiment. The current price is nearing its 52-week high, suggesting a momentum-driven valuation rather than a fundamental one.

TSEM exhibits a stable financial health profile with a Piotroski F-Score of 4/9 and an exceptionally strong balance sheet characterized by negligible debt. However, the stock is severely overvalued, trading at $224.49—nearly four times its growth-based intrinsic value of $56.93 and nearly seven times its Graham Number of $33.56. While earnings growth is robust, the P/E of 116.32 and PEG of 5.44 indicate that the current price has far outpaced fundamental growth. The combination of a bearish technical trend (10/100) and a current price significantly above the analyst target of $168.57 suggests a high risk of a correction.